RED+BLUE STRATEGIES for EXPRESS SCRIPTS INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 5, 2012 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Jul 5, 2012 | $60,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Monitoring ongoing Medicare and Medicaid regulations and guidance related to prescription medications, PBMs and related entities. Monitoring potential health-related offsets being considered as part of the end of the year wrap package related to Medicare Part D and Medicaid pharmacy benefits. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Pharmacy PHA
H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Health Issues HCR
Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing, Health Information Technology, and Essential Health Benefits. Reauthorization of the Prescription Drug User Fee Act, specifically issues related to track and trace policies and exclusivity. Issues related regulations that have the potential to the survey of mail order and specialty pharmacies for Medicaid purposes. Proposed OPM-focused policies in the Administration's 2013 Budget related to the utilization of Pharmacy Benefit Managers. S. 3187 - The FDA Safety and Innovation Act - Specifically issues regarding down stream supply chain policies and provisions related to the treatment of controlled substances.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN HAUCK MARSHALL | — |
| MELANIE JAN NATHANSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.